These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24634930)

  • 1. Prognosis assessment of patients with refractory ascites treated with a peritoneovenous shunt.
    Nitta H; Okamura S; Mizumoto T; Matsushita H; Nishimura T; Shimokawa Y; Kimura M; Baba H
    Hepatogastroenterology; 2013 Oct; 60(127):1607-10. PubMed ID: 24634930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Factors for Treatment Failure after Peritoneovenous Shunt for Hepatic Ascites.
    Iida H; Aihara T; Ikuta S; Yamanaka N
    Am Surg; 2017 Nov; 83(11):1289-1293. PubMed ID: 29183533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.
    Guardiola J; Xiol X; Escribá JM; Castellví JM; Castellote J; Baliellas C; Rafecas A; Casais LA
    Am J Gastroenterol; 1995 Dec; 90(12):2097-102. PubMed ID: 8540495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites.
    Moreau R; Delègue P; Pessione F; Hillaire S; Durand F; Lebrec D; Valla DC
    Liver Int; 2004 Oct; 24(5):457-64. PubMed ID: 15482343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneovenous shunting for cirrhotic versus malignant ascites.
    Kostroff KM; Ross DW; Davis JM
    Surg Gynecol Obstet; 1985 Sep; 161(3):204-8. PubMed ID: 2412302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgical treatment of refractory ascites with peritoneovenous shunt and its complications].
    Brescia A; La Torre F; Pieralisi G
    Ann Ital Chir; 1983; 55(4):385-93. PubMed ID: 6673622
    [No Abstract]   [Full Text] [Related]  

  • 7. [Peritoneovenous shunting in intractable ascites of cirrhosis. Results of a prospective study on improving prognostic factors].
    Hillaire S; Labianca M; Smadja C; Grange D; Franco D
    Gastroenterol Clin Biol; 1988 Oct; 12(10):681-6. PubMed ID: 3220223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Denver peritoneojugular shunt. Current indications].
    Bracci F; Bracaglia C; Zampino MA; Farina F; Cucchiara G
    Minerva Med; 1989 Apr; 80(4):363-6. PubMed ID: 2725937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous peritoneovenous shunt for treatment of refractory ascites.
    Won JY; Choi SY; Ko HK; Kim SH; Lee KH; Lee JT; Lee DY
    J Vasc Interv Radiol; 2008 Dec; 19(12):1717-22. PubMed ID: 18948021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerosing encapsulating peritonitis in a liver transplant patient: a case report.
    Lin CH; Yu JC; Chen TW; Chan DC; Chen CJ; Hsieh CB
    World J Gastroenterol; 2005 Sep; 11(34):5412-3. PubMed ID: 16149160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-infective complications of peritoneovenous anastomosis (LeVeen shunt)].
    Castells LL; Comas P; Lucea D; Charco R; González A; Vargas V
    Rev Esp Enferm Dig; 1992 Nov; 82(5):368-9. PubMed ID: 1485993
    [No Abstract]   [Full Text] [Related]  

  • 12. Peritoneovenous shunts in patients with intractable ascites: palliation at what price?
    Zervos EE; McCormick J; Goode SE; Rosemurgy AS
    Am Surg; 1997 Feb; 63(2):157-62. PubMed ID: 9012430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneovenous shunting for intractable ascites.
    Gullstrand P; Alwmark A; Börjesson B; Joelsson B; Bengmark S
    Scand J Gastroenterol; 1982 Nov; 17(8):1009-12. PubMed ID: 7167735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis.
    Koyama S; Nogami A; Yoneda M; Cheng S; Koike Y; Takeuchi Y; Iwaki M; Kobayashi T; Saito S; Utsunomiya D; Nakajima A
    Tomography; 2024 Mar; 10(4):471-479. PubMed ID: 38668394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peritoneovenous shunt in ascites].
    Vasilev S; Baev S; Ivanov S
    Khirurgiia (Sofiia); 1990; 43(2):36-41. PubMed ID: 2398693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneovenous shunts palliate malignant ascites.
    Edney JA; Hill A; Armstrong D
    Am J Surg; 1989 Dec; 158(6):598-601. PubMed ID: 2480068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity and mortality after peritoneovenous shunt surgery for refractory ascites.
    Rubinstein D; McInnes I; Dudley F
    Gut; 1985 Oct; 26(10):1070-3. PubMed ID: 4054706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Irreducible ascites in cirrhotic patients. Results of peritoneo-jugular shunt in 16 patients (author's transl)].
    Paliard P; Partensky C; Saubier E
    Nouv Presse Med; 1981 Sep; 10(33):2715-8. PubMed ID: 6974851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant impact of patient age on outcome after liver resection for HCC in cirrhosis.
    Faber W; Stockmann M; Schirmer C; Möllerarnd A; Denecke T; Bahra M; Klein F; Schott E; Neuhaus P; Seehofer D
    Eur J Surg Oncol; 2014 Feb; 40(2):208-13. PubMed ID: 24275202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.